Tokyo Tape
Sign in
← Hyuga Primary Care

Quarterly report · Q2

7133.TEDINET S100S8NI
Period2023-04-01 → 2023-09-30
Filed2023-11-13
StandardJapan GAAP
ConsolidatedNo
Data checks12 of 12 passed
Key figures · 50
MetricValuePeriodScopeSource row
Revenue¥3.9bn2023-04-01 → 2023-09-30StandaloneNet sales
Revenue¥6.7bn2022-04-01 → 2023-03-31StandaloneNet sales (5-year summary)
Revenue¥3.2bn2022-04-01 → 2022-09-30StandaloneNet sales
Operating income¥201m2023-04-01 → 2023-09-30StandaloneOperating income
Operating income¥255m2022-04-01 → 2022-09-30StandaloneOperating income
Ordinary income¥200m2023-04-01 → 2023-09-30StandaloneOrdinary income
Ordinary income¥558m2022-04-01 → 2023-03-31StandaloneOrdinary income loss (5-year summary)
Ordinary income¥263m2022-04-01 → 2022-09-30StandaloneOrdinary income
Profit before tax¥200m2023-04-01 → 2023-09-30StandaloneIncome before income taxes
Profit before tax¥263m2022-04-01 → 2022-09-30StandaloneIncome before income taxes
Net income¥135m2023-04-01 → 2023-09-30StandaloneProfit loss
Net income¥383m2022-04-01 → 2023-03-31StandaloneNet income loss (5-year summary)
Net income¥179m2022-04-01 → 2022-09-30StandaloneProfit loss
Total assets¥4.0bnat 2023-09-30StandaloneAssets
Total assets¥2.9bnat 2023-03-31StandaloneAssets
Total assets¥2.8bnat 2022-09-30StandaloneTotal assets (5-year summary)
Total liabilities¥2.4bnat 2023-09-30StandaloneLiabilities
Total liabilities¥1.4bnat 2023-03-31StandaloneLiabilities
Net assets / equity¥1.6bnat 2023-09-30StandaloneNet assets
Net assets / equity¥1.5bnat 2023-03-31StandaloneNet assets
Net assets / equity¥1.3bnat 2022-09-30StandaloneNet assets (5-year summary)
Cash and deposits¥854mat 2023-09-30StandaloneCash and deposits
Cash and deposits¥568mat 2023-03-31StandaloneCash and deposits
Cash & equivalents¥854mat 2023-09-30StandaloneCash and cash equivalents
Cash & equivalents¥568mat 2023-03-31StandaloneCash and cash equivalents
Cash & equivalents¥680mat 2022-09-30StandaloneCash and cash equivalents
Cash & equivalents¥720mat 2022-03-31dStandaloneCash and cash equivalents
Operating cash flow¥230m2023-04-01 → 2023-09-30StandaloneNet cash provided by used in operating activities
Operating cash flow¥342m2022-04-01 → 2023-03-31StandaloneNet cash provided by used in operating activities (5-year summary)
Operating cash flow¥97m2022-04-01 → 2022-09-30StandaloneNet cash provided by used in operating activities
Investing cash flow−¥436m2023-04-01 → 2023-09-30StandaloneNet cash provided by used in investment activities
Investing cash flow−¥383m2022-04-01 → 2023-03-31StandaloneNet cash provided by used in investing activities (5-year summary)
Investing cash flow−¥193m2022-04-01 → 2022-09-30StandaloneNet cash provided by used in investment activities
Financing cash flow¥492m2023-04-01 → 2023-09-30StandaloneNet cash provided by used in financing activities
Financing cash flow−¥111m2022-04-01 → 2023-03-31StandaloneNet cash provided by used in financing activities (5-year summary)
Financing cash flow¥57m2022-04-01 → 2022-09-30StandaloneNet cash provided by used in financing activities
EPS (basic)¥18.822023-04-01 → 2023-09-30StandaloneBasic earnings loss per share (5-year summary)
EPS (basic)¥13.722023-07-01 → 2023-09-30dStandaloneBasic earnings loss per share (5-year summary)
EPS (basic)¥53.922022-04-01 → 2023-03-31StandaloneBasic earnings loss per share (5-year summary)
EPS (basic)¥25.332022-04-01 → 2022-09-30StandaloneBasic earnings loss per share (5-year summary)
EPS (basic)¥12.252022-07-01 → 2022-09-30dStandaloneBasic earnings loss per share (5-year summary)
EPS (diluted)¥17.922023-04-01 → 2023-09-30StandaloneDiluted earnings per share (5-year summary)
EPS (diluted)¥50.822022-04-01 → 2023-03-31StandaloneDiluted earnings per share (5-year summary)
EPS (diluted)¥23.742022-04-01 → 2022-09-30StandaloneDiluted earnings per share (5-year summary)
Equity ratio39.7%at 2023-09-30StandaloneEquity to asset ratio (5-year summary)
Equity ratio50.9%at 2023-03-31StandaloneEquity to asset ratio (5-year summary)
Equity ratio46.4%at 2022-09-30StandaloneEquity to asset ratio (5-year summary)
Shares issued7,156,600at 2023-09-30StandaloneTotal number of issued shares (5-year summary)
Shares issued3,572,000at 2023-03-31StandaloneTotal number of issued shares (5-year summary)
Shares issued3,568,400at 2022-09-30StandaloneTotal number of issued shares (5-year summary)

Periods use the dates stated in the filing. d = earlier-year period dated by calendar; v = that date confirmed by the company's own earlier filing.

Segments · 38
SegmentItemPeriodValue
Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segmentsrevenue2023-04-01 → 2023-09-30¥16m
Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segmentsrevenue external2023-04-01 → 2023-09-30¥16m
Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segmentssegment profit2023-04-01 → 2023-09-30−¥6m
Reconciling Itemsreconcilingsegment profit2023-04-01 → 2023-09-30−¥230m
jpcrp040300-q2r_E37198-000Home Visit Pharmacist Servicereportable segmentrevenue2023-04-01 → 2023-09-30¥3.2bn
jpcrp040300-q2r_E37198-000Home Visit Pharmacist Servicereportable segmentrevenue external2023-04-01 → 2023-09-30¥3.2bn
jpcrp040300-q2r_E37198-000Home Visit Pharmacist Servicereportable segmentsegment profit2023-04-01 → 2023-09-30¥298m
jpcrp040300-q2r_E37198-000Kirari Primereportable segmentrevenue2023-04-01 → 2023-09-30¥377m
jpcrp040300-q2r_E37198-000Kirari Primereportable segmentrevenue external2023-04-01 → 2023-09-30¥377m
jpcrp040300-q2r_E37198-000Kirari Primereportable segmentsegment profit2023-04-01 → 2023-09-30¥206m
jpcrp040300-q2r_E37198-000Primary Care Homereportable segmentrevenue2023-04-01 → 2023-09-30¥288m
jpcrp040300-q2r_E37198-000Primary Care Homereportable segmentrevenue external2023-04-01 → 2023-09-30¥288m
jpcrp040300-q2r_E37198-000Primary Care Homereportable segmentsegment profit2023-04-01 → 2023-09-30−¥67m
—segment totalrevenue2023-04-01 → 2023-09-30¥3.9bn
—segment totalrevenue external2023-04-01 → 2023-09-30¥3.9bn
—segment totalsegment profit2023-04-01 → 2023-09-30¥436m
Total Of Reportable Segments And Otherssegment totalrevenue2023-04-01 → 2023-09-30¥3.9bn
Total Of Reportable Segments And Otherssegment totalrevenue external2023-04-01 → 2023-09-30¥3.9bn
Total Of Reportable Segments And Otherssegment totalsegment profit2023-04-01 → 2023-09-30¥431m
Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segmentsrevenue2022-04-01 → 2022-09-30¥28m
Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segmentsrevenue external2022-04-01 → 2022-09-30¥28m
Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segmentssegment profit2022-04-01 → 2022-09-30¥4m
Reconciling Itemsreconcilingsegment profit2022-04-01 → 2022-09-30−¥192m
jpcrp040300-q2r_E37198-000Home Visit Pharmacist Servicereportable segmentrevenue2022-04-01 → 2022-09-30¥2.8bn
jpcrp040300-q2r_E37198-000Home Visit Pharmacist Servicereportable segmentrevenue external2022-04-01 → 2022-09-30¥2.8bn
jpcrp040300-q2r_E37198-000Home Visit Pharmacist Servicereportable segmentsegment profit2022-04-01 → 2022-09-30¥339m
jpcrp040300-q2r_E37198-000Kirari Primereportable segmentrevenue2022-04-01 → 2022-09-30¥275m
jpcrp040300-q2r_E37198-000Kirari Primereportable segmentrevenue external2022-04-01 → 2022-09-30¥275m
jpcrp040300-q2r_E37198-000Kirari Primereportable segmentsegment profit2022-04-01 → 2022-09-30¥144m
jpcrp040300-q2r_E37198-000Primary Care Homereportable segmentrevenue2022-04-01 → 2022-09-30¥65m
jpcrp040300-q2r_E37198-000Primary Care Homereportable segmentrevenue external2022-04-01 → 2022-09-30¥65m
jpcrp040300-q2r_E37198-000Primary Care Homereportable segmentsegment profit2022-04-01 → 2022-09-30−¥40m
—segment totalrevenue2022-04-01 → 2022-09-30¥3.1bn
—segment totalrevenue external2022-04-01 → 2022-09-30¥3.1bn
—segment totalsegment profit2022-04-01 → 2022-09-30¥443m
Total Of Reportable Segments And Otherssegment totalrevenue2022-04-01 → 2022-09-30¥3.2bn
Total Of Reportable Segments And Otherssegment totalrevenue external2022-04-01 → 2022-09-30¥3.2bn
Total Of Reportable Segments And Otherssegment totalsegment profit2022-04-01 → 2022-09-30¥447m

Segment names come from EDINET member IDs; not yet mapped to a common taxonomy.

All source rows · 442
ItemContextValueUnit
Operating incomePrior1YTDDuration_NonConsolidatedMember_TotalOfReportableSegmentsAndOthersMember446908000JPY
Operating incomePrior1YTDDuration_NonConsolidatedMember_ReconcilingItemsMember-192042000JPY
Operating incomePrior1YTDDuration_NonConsolidatedMember254866000JPY
Revenues from external customersCurrentYTDDuration_NonConsolidatedMember_jpcrp040300-q2r_E37198-000HomeVisitPharmacistServiceReportableSegmentsMember3218327000JPY
Revenues from external customersCurrentYTDDuration_NonConsolidatedMember_jpcrp040300-q2r_E37198-000KirariPrimeReportableSegmentsMember377120000JPY
Revenues from external customersCurrentYTDDuration_NonConsolidatedMember_jpcrp040300-q2r_E37198-000PrimaryCareHomeReportableSegmentsMember287735000JPY
Revenues from external customersCurrentYTDDuration_NonConsolidatedMember_ReportableSegmentsMember3883183000JPY
Revenues from external customersCurrentYTDDuration_NonConsolidatedMember_OperatingSegmentsNotIncludedInReportableSegmentsAndOtherRevenueGeneratingBusinessActivitiesMember16030000JPY
Revenues from external customersCurrentYTDDuration_NonConsolidatedMember_TotalOfReportableSegmentsAndOthersMember3899214000JPY
Revenues from external customersCurrentYTDDuration_NonConsolidatedMember_ReconcilingItemsMember－JPY
Revenues from external customersCurrentYTDDuration_NonConsolidatedMember3899214000JPY
Transactions with other segmentsCurrentYTDDuration_NonConsolidatedMember_jpcrp040300-q2r_E37198-000HomeVisitPharmacistServiceReportableSegmentsMember－JPY
Transactions with other segmentsCurrentYTDDuration_NonConsolidatedMember_jpcrp040300-q2r_E37198-000KirariPrimeReportableSegmentsMember－JPY
Transactions with other segmentsCurrentYTDDuration_NonConsolidatedMember_jpcrp040300-q2r_E37198-000PrimaryCareHomeReportableSegmentsMember－JPY
Transactions with other segmentsCurrentYTDDuration_NonConsolidatedMember_ReportableSegmentsMember－JPY
Transactions with other segmentsCurrentYTDDuration_NonConsolidatedMember_OperatingSegmentsNotIncludedInReportableSegmentsAndOtherRevenueGeneratingBusinessActivitiesMember－JPY
Transactions with other segmentsCurrentYTDDuration_NonConsolidatedMember_TotalOfReportableSegmentsAndOthersMember－JPY
Transactions with other segmentsCurrentYTDDuration_NonConsolidatedMember_ReconcilingItemsMember－JPY
Transactions with other segmentsCurrentYTDDuration_NonConsolidatedMember－JPY
Net salesCurrentYTDDuration_NonConsolidatedMember_jpcrp040300-q2r_E37198-000HomeVisitPharmacistServiceReportableSegmentsMember3218327000JPY
Net salesCurrentYTDDuration_NonConsolidatedMember_jpcrp040300-q2r_E37198-000KirariPrimeReportableSegmentsMember377120000JPY
Net salesCurrentYTDDuration_NonConsolidatedMember_jpcrp040300-q2r_E37198-000PrimaryCareHomeReportableSegmentsMember287735000JPY
Net salesCurrentYTDDuration_NonConsolidatedMember_ReportableSegmentsMember3883183000JPY
Net salesCurrentYTDDuration_NonConsolidatedMember_OperatingSegmentsNotIncludedInReportableSegmentsAndOtherRevenueGeneratingBusinessActivitiesMember16030000JPY
Net salesCurrentYTDDuration_NonConsolidatedMember_TotalOfReportableSegmentsAndOthersMember3899214000JPY
Net salesCurrentYTDDuration_NonConsolidatedMember_ReconcilingItemsMember－JPY
Net salesCurrentYTDDuration_NonConsolidatedMember3899214000JPY
Operating incomeCurrentYTDDuration_NonConsolidatedMember_jpcrp040300-q2r_E37198-000HomeVisitPharmacistServiceReportableSegmentsMember297681000JPY
Operating incomeCurrentYTDDuration_NonConsolidatedMember_jpcrp040300-q2r_E37198-000KirariPrimeReportableSegmentsMember205802000JPY
Operating incomeCurrentYTDDuration_NonConsolidatedMember_jpcrp040300-q2r_E37198-000PrimaryCareHomeReportableSegmentsMember-67097000JPY
Operating incomeCurrentYTDDuration_NonConsolidatedMember_ReportableSegmentsMember436386000JPY
Operating incomeCurrentYTDDuration_NonConsolidatedMember_OperatingSegmentsNotIncludedInReportableSegmentsAndOtherRevenueGeneratingBusinessActivitiesMember-5635000JPY
Operating incomeCurrentYTDDuration_NonConsolidatedMember_TotalOfReportableSegmentsAndOthersMember430750000JPY
Operating incomeCurrentYTDDuration_NonConsolidatedMember_ReconcilingItemsMember-229737000JPY
Operating incomeCurrentYTDDuration_NonConsolidatedMember201013000JPY
Document title cover pageFilingDateInstant
Original text (Japanese)四半期報告書
Clause of stipulation cover pageFilingDateInstant
Original text (Japanese)金融商品取引法第24条の４の７第１項
Place of filing cover pageFilingDateInstant
Original text (Japanese)福岡財務支局長
Filing date cover pageFilingDateInstant2023-11-13
Quarterly accounting period cover pageFilingDateInstant
Original text (Japanese)第17期第２四半期（自　2023年７月１日　至　2023年９月30日）
Company name cover pageFilingDateInstant
Original text (Japanese)ＨＹＵＧＡ　ＰＲＩＭＡＲＹ　ＣＡＲＥ株式会社
Company name in english cover pageFilingDateInstantＨＹＵＧＡ　ＰＲＩＭＡＲＹ　ＣＡＲＥ　Ｃｏ．，Ｌｔｄ．
Title and name of representative cover pageFilingDateInstant
Original text (Japanese)代表取締役社長　　黒木　哲史
Address of registered headquarter cover pageFilingDateInstant
Original text (Japanese)福岡県春日市春日原北町二丁目２番１号
Telephone number address of registered headquarter cover pageFilingDateInstant
Original text (Japanese)092-558-2120（代表）
Name of contact person address of registered headquarter cover pageFilingDateInstant
Original text (Japanese)取締役最高財務責任者　大西　智明
Nearest place of contact cover pageFilingDateInstant
Original text (Japanese)福岡県春日市春日原北町二丁目２番１号
Telephone number nearest place of contact cover pageFilingDateInstant
Original text (Japanese)092-558-2120（代表）
Name of contact person nearest place of contact cover pageFilingDateInstant
Original text (Japanese)取締役最高財務責任者　大西　智明
Place for public inspection cover page (text)FilingDateInstantText · Plus

Every row of the EDINET CSV. Item names are the XBRL element names; filed text is kept in its original Japanese. Filed text is available on Plus and Pro.

Data checks · 12 of 12 passed
balance sheet identitynon_consolidated 2023-03-31pass rounding
balance sheet identitynon_consolidated 2023-09-30pass
dei present pass
period resolution pass
statement vs summary · net assetsnon_consolidated 2023-03-31pass
statement vs summary · net assetsnon_consolidated 2023-09-30pass
statement vs summary · operating cash flownon_consolidated 2022-04-01/2022-09-30pass
statement vs summary · operating cash flownon_consolidated 2023-04-01/2023-09-30pass
statement vs summary · revenuenon_consolidated 2022-04-01/2022-09-30pass
statement vs summary · revenuenon_consolidated 2023-04-01/2023-09-30pass
statement vs summary · total assetsnon_consolidated 2023-03-31pass
statement vs summary · total assetsnon_consolidated 2023-09-30pass